{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:11:42Z","timestamp":1783516302435,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004027","name":"Heilongjiang Postdoctoral","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274028"],"award-info":[{"award-number":["82274028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017366","name":"Key Research and Development Program of Heilongjiang","doi-asserted-by":"publisher","award":["2022ZX02C09"],"award-info":[{"award-number":["2022ZX02C09"]}],"id":[{"id":"10.13039\/100017366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["HYD2020JQ0018"],"award-info":[{"award-number":["HYD2020JQ0018"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Environmental Toxicology and Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.etap.2023.104142","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T15:06:43Z","timestamp":1683126403000},"page":"104142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Type 2 diabetes affects arsenic metabolism via transporters in arsenic trioxide treated acute promyelocytic leukemia patients"],"prefix":"10.1016","volume":"100","author":[{"given":"Mengliang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Hostetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.etap.2023.104142_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1124\/mol.113.091314","article-title":"A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4\/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII)","volume":"v. 86","author":"Banerjee","year":"2014","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.etap.2023.104142_bib2","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0437994100","article-title":"Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver","volume":"v. 100","author":"Carbrey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.etap.2023.104142_bib3","article-title":"Urinary total arsenic and arsenic methylation capacity in pregnancy and gestational diabetes mellitus: a case-control study","volume":"v. 271","author":"Chen","year":"2021","journal-title":"Chemosphere"},{"issue":"2","key":"10.1016\/j.etap.2023.104142_bib4","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202001299RR","article-title":"Multidrug resistance-associated protein 4 (Mrp4) is a novel genetic factor in the pathogenesis of obesity and diabetes","volume":"v. 35","author":"Donepudi","year":"2021","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.etap.2023.104142_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00280-018-3606-8","article-title":"Clinical pharmacokinetics and safety profile of single agent arsenic trioxide by continuous slow-rate infusion in patients with newly diagnosed acute promyelocytic leukemia","volume":"v. 82","author":"Gao","year":"2018","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.etap.2023.104142_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.envint.2019.02.058","article-title":"Pathways of arsenic uptake and efflux","volume":"v. 126","author":"Garbinski","year":"2019","journal-title":"Environ. Int"},{"key":"10.1016\/j.etap.2023.104142_bib7","first-page":"10","article-title":"Incidence of differentiation syndrome associated with treatment regimens in acute myeloid leukemia: a systematic review of the literature","volume":"v. 9","author":"Gasparovic","year":"2020","journal-title":"J. Clin. Med."},{"issue":"11","key":"10.1016\/j.etap.2023.104142_bib8","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/cncr.31327","article-title":"Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study","volume":"v. 124","author":"Gill","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.etap.2023.104142_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/17512433.2021.1893940","article-title":"Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide","volume":"v. 14","author":"Guo","year":"2021","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.etap.2023.104142_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003088-199120060-00004","article-title":"The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans","volume":"v. 20","author":"Gwilt","year":"1991","journal-title":"Clin. Pharm."},{"issue":"14","key":"10.1016\/j.etap.2023.104142_bib11","doi-asserted-by":"crossref","first-page":"23905","DOI":"10.18632\/oncotarget.14733","article-title":"Metabolism, toxicity and anticancer activities of arsenic compounds","volume":"v. 8","author":"Khairul","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.etap.2023.104142_bib12","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1248\/bpb.b13-00369","article-title":"Functional alterations of intestinal P-glycoprotein under diabetic conditions","volume":"v. 36","author":"Kobori","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.etap.2023.104142_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/14740338.3.6.589","article-title":"Arsenic trioxide in the treatment of haematological malignancies","volume":"v. 3","author":"Kwong","year":"2004","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.etap.2023.104142_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jinorgbio.2011.11.009","article-title":"Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs\/ABCCs)","volume":"v. 108","author":"Leslie","year":"2012","journal-title":"J. Inorg. Biochem"},{"issue":"1\u20132","key":"10.1016\/j.etap.2023.104142_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(01)00532-7","article-title":"Multidrug-resistance mdr1a\/1b double knockout mice are more sensitive than wild type mice to acute arsenic toxicity, with higher arsenic accumulation in tissues","volume":"v. 170","author":"Liu","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.etap.2023.104142_bib16","article-title":"Pharmacokinetic characteristics, tissue bioaccumulation and toxicity profiles of oral arsenic trioxide in rats: implications for the treatment and risk assessment of acute promyelocytic leukemia","volume":"v. 12","author":"Liu","year":"2021","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.etap.2023.104142_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2006.10.054","article-title":"Mammalian glucose permease GLUT1 facilitates transport of arsenic trioxide and methylarsonous acid","volume":"v. 351","author":"Liu","year":"2006","journal-title":"Biochem Biophys. Res Commun."},{"issue":"3","key":"10.1016\/j.etap.2023.104142_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/03602532.2020.1791173","article-title":"Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts","volume":"v. 52","author":"Maimaitiyiming","year":"2020","journal-title":"Drug Metab. Rev."},{"issue":"5","key":"10.1016\/j.etap.2023.104142_bib19","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bbagen.2013.11.021","article-title":"Aquaglyceroporins: generalized metalloid channels","volume":"v. 1840","author":"Mukhopadhyay","year":"2014","journal-title":"Biochim Biophys. Acta"},{"issue":"5","key":"10.1016\/j.etap.2023.104142_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0090-9556(25)08785-9","article-title":"Comparative pharmacokinetics of cefoperazone and cephradine in untreated streptozotocin diabetic rats","volume":"v. 20","author":"Nakashima","year":"1992","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.etap.2023.104142_bib21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the randomized Italian-German APL0406 trial","volume":"v. 35","author":"Platzbecker","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.etap.2023.104142_bib22","doi-asserted-by":"crossref","first-page":"F956","DOI":"10.1152\/ajprenal.00314.2006","article-title":"AQP7 is localized in capillaries of adipose tissue, cardiac and striated muscle: implications in glycerol metabolism","volume":"v. 292","author":"Skowronski","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.etap.2023.104142_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/tox.20717","article-title":"Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment","volume":"v. 28","author":"Wang","year":"2013","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.etap.2023.104142_bib24","article-title":"Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia","volume":"v. 409","author":"Wang","year":"2020","journal-title":"Toxicol. Appl. Pharm."},{"issue":"3","key":"10.1016\/j.etap.2023.104142_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1039\/c9mt00308h","article-title":"Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases","volume":"v. 12","author":"Wang","year":"2020","journal-title":"Metallomics"},{"issue":"1","key":"10.1016\/j.etap.2023.104142_bib26","doi-asserted-by":"crossref","first-page":"F99","DOI":"10.1152\/ajprenal.00466.2009","article-title":"Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis","volume":"v. 299","author":"Wang","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.etap.2023.104142_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbrc.2018.06.029","article-title":"Molecular mechanism of the increased tissue uptake of trivalent inorganic arsenic in mice with type 1 diabetes mellitus","volume":"v. 504","author":"Wei","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.etap.2023.104142_bib28","first-page":"7","article-title":"Arsenic exposure, arsenic metabolism, and glycemia: results from a clinical population in New York City","volume":"v. 18","author":"Wu","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"issue":"6","key":"10.1016\/j.etap.2023.104142_bib29","first-page":"123","article-title":"Acute promyelocytic leukemia current treatment algorithms: blood","volume":"v. 11","author":"Yilmaz","year":"2021","journal-title":"Cancer J."}],"container-title":["Environmental Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1382668923000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:27:32Z","timestamp":1778606852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1382668923000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":29,"alternative-id":["S1382668923000844"],"URL":"https:\/\/doi.org\/10.1016\/j.etap.2023.104142","relation":{},"ISSN":["1382-6689"],"issn-type":[{"value":"1382-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes affects arsenic metabolism via transporters in arsenic trioxide treated acute promyelocytic leukemia patients","name":"articletitle","label":"Article Title"},{"value":"Environmental Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.etap.2023.104142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104142"}}